Phase IB/II Study of Lirilumab with Azacytidine (AZA) in Relapsed AML
Year: 2017
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Naval Daver, Prajwal Boddu, Guillermo Garcia‐Manero, Farhad Ravandi, Elias Jabbour, Gautam Borthakur, Courtney D. DiNardo, Marina Konopleva, Naveen Pemmaraju, Tapan M. Kadia, Nitin Jain, Sherry Pierce, Wilmer Flores, Steven M. Kornblau, Nawar R. Hussain, Jing Ning, Graciela Nogueras González, Sreyashi Basu, Jorge E. Cortés, Padmanee Sharma, Hagop M. Kantarjian
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3183362699